about
Treatment of infantile spasmsTreatment of infantile spasmsEarly-onset epileptic encephalopathies and the diagnostic approach to underlying causesWhat is the importance of abnormal "background" activity in seizure generation?The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America.The cell-intrinsic requirement of Sox6 for cortical interneuron development.Continuous spike-waves during slow-wave sleep in a mouse model of focal cortical dysplasiaEffect of Seizures on the Developing Brain and Cognition.What is more harmful, seizures or epileptic EEG abnormalities? Is there any clinical data?Interictal spikes in developing rats cause long-standing cognitive deficitsTreating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.Analysis of mutations in 7 genes associated with neuronal excitability and synaptic transmission in a cohort of children with non-syndromic infantile epileptic encephalopathy.Epileptic encephalopathies in adults and childhood.Seizure aggravation in idiopathic generalized epilepsies.Role of valproate across the ages. Treatment of epilepsy in children.Autism and epilepsy: what has regression got to do with it?The epidemiology of convulsive status epilepticus in children: a critical review.Neuropsychological deficits in childhood epilepsy syndromes.Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy).Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience.Blinders, phenotype, and fashionable genetic analysis: a critical examination of the current state of epilepsy genetic studies."Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandingsUpdate on rufinamide in childhood epilepsy.Changing perspectives on Landau-Kleffner syndrome.Ketogenic diet in epileptic encephalopathies.The Epilepsy Spectrum: Targeting Future Research Challenges.Current Treatment Options for Early-Onset Pediatric Epileptic Encephalopathies.Substantial and sustained seizure reduction with ketogenic diet in a patient with Ohtahara syndrome.Why Are Children With Epileptic Encephalopathies Encephalopathic?Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy.Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.Episodic epileptic verbal auditory agnosia in Landau Kleffner syndrome treated with combination diazepam and corticosteroids.Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures.The spectrum of SCN1A-related infantile epileptic encephalopathies.Cortical excitability decreases in Lennox-Gastaut syndrome.CDKL5 alterations lead to early epileptic encephalopathy in both genders.
P2860
Q24202185-0CD7478B-1F9D-439A-9A2F-789314F8D605Q24241001-0929B983-F9ED-45D1-91F9-74D5AE0A7B36Q26773828-D5AF2799-A79D-4B1D-A211-B49BC806ABFCQ26827508-0A848796-09BD-4C5F-8998-3671EAB52AE5Q27312713-E459C297-028A-4FD1-810C-CE6416FCCBACQ30491441-7138AB20-0344-46C6-A237-520798301225Q30848115-1934DD1B-F867-48AE-9BEB-4DF411ACA910Q33618960-03564CA8-27BA-46F5-A551-BD3ACB61DF7EQ33618978-80F05B4E-48A2-4A03-B7F8-F0A8DC191E95Q34020765-D977E350-A8F2-4207-BFB3-D967D7E75121Q34184171-2CAB39BE-9E2A-4F58-AD87-A22B937BA02FQ35581412-9FCDA0C8-D32C-4635-AADA-8636EF9EB34AQ36302381-F982C29F-D63C-4367-B0DC-96EE918982B3Q36319430-30DF6E03-6856-4E31-B028-40C3A681049BQ36507532-B9422D5D-65BE-45AE-B3C0-90F78CF58BE6Q36720971-868D8716-CBF4-4863-A482-68D51DE98798Q36883181-F04B7F0A-EA91-4C7E-8F2A-EE4E0A67F492Q36982516-A9967D7E-1552-44B9-AC92-4C78FA4EA43FQ37125505-D114AA79-8948-48B3-BADB-5D6A74360FAFQ37826764-D21F52B0-0F7E-4C45-AC69-7136306668E6Q37827176-CEECC688-3F6D-4D6C-8AE9-7E0D3DE2930DQ37883054-E80A7718-86F3-4B42-8551-7FF8CAE50F92Q37906275-2968965F-AC4E-4F53-A60B-DE38DDA2EA47Q37939980-C8ADB0AA-0D4C-495B-84BA-34D82F090AADQ38128307-1274FD6F-83A0-4BBA-8E67-AE11461C4ED5Q38846021-98D99024-8947-4FDE-8157-01AF9F7A6A55Q38946719-CA957986-8851-42A8-A898-1D986E93FC64Q40813981-9D5841C1-9E12-4DC7-9FFE-D8AAE1CFDE17Q43101476-E955D599-8865-4B38-837C-AB801ED8AF74Q44455077-340D08D5-7CAB-4832-87DE-07C269C5940EQ47562691-FB0D9AE5-50DA-4006-BB9D-2EF97DBDB17DQ47921035-C4064695-3EA4-4DDA-80C8-660D5403DB18Q48227529-7AA72C60-3491-4E23-AB99-51AE478B4C39Q48249670-3F83C440-0063-426B-A374-11D573389395Q48435179-FA7B9324-D3AF-4AFF-BE24-A7CDE2D8C88DQ49032666-26320B68-A082-4279-A4F3-595DBE497D3D
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Epileptic encephalopathies: a brief overview.
@ast
Epileptic encephalopathies: a brief overview.
@en
type
label
Epileptic encephalopathies: a brief overview.
@ast
Epileptic encephalopathies: a brief overview.
@en
prefLabel
Epileptic encephalopathies: a brief overview.
@ast
Epileptic encephalopathies: a brief overview.
@en
P1476
Epileptic encephalopathies: a brief overview.
@en
P2093
Olivier Dulac
Rima Nabbout
P304
P356
10.1097/00004691-200311000-00002
P577
2003-11-01T00:00:00Z